Skip Navigation LinksHome > March 2014 - Volume 52 - Issue 3 > Weight Loss and Outcomes in Wait-listed, Medically Managed,...
Medical Care:
doi: 10.1097/MLR.0000000000000070
Original Articles

Weight Loss and Outcomes in Wait-listed, Medically Managed, and Surgically Treated Patients Enrolled in a Population-based Bariatric Program: Prospective Cohort Study

Padwal, Raj S. MD, MSc*,†; Rueda-Clausen, Christian F. MD, PhD*,†; Sharma, Arya M. MD, PhD*,†; Agborsangaya, Calypse B. MSc*,†; Klarenbach, Scott MD, MSc*; Birch, Dan W. MD; Karmali, Shahzeer MD; McCargar, Linda§; Majumdar, Sumit R. MD, MPH*,†

Supplemental Author Material
Collapse Box

Abstract

Background:

Multidisciplinary bariatric care is increasingly being delivered in Canada within publicly funded regional programs. Demand is high, wait lists are long, and clinical effectiveness is unknown.

Objective:

To examine the “real-world” outcomes associated with a publicly funded, population-based regional bariatric (medical and surgical) program.

Research Design:

Prospective observational cohort.

Subjects:

Five hundred consecutive patients (150 wait-listed, 200 medically treated, 150 surgically treated) from the Edmonton Weight Wise program were enrolled.

Measures:

The primary outcome was weight change (kg). Between-group changes were analyzed using multivariable regression adjusted for age, sex, and baseline weight and “last-observation-carried-forward” was used for missing data. Subjects transitioning between groups (wait-list to medical or medical to surgery) were censored when crossing over.

Results:

At baseline, mean age was 43.7±9.6 years, mean body mass index was 47.9±8.1 kg/m2, and 88% were female. A total of 412 subjects (82%) completed 2-year follow-up and 143 (29%) subjects crossed over to the next treatment phase. Absolute and relative (% of baseline) mean weight reductions were 1.5±8.5 kg (0.9±6.1%) for wait-listed, 4.1±11.6 kg (2.8±8.1%) for medically treated, and 22.0±19.7 kg (16.3±13.5%) for surgically treated (P<0.001) subjects. For surgery, weight reductions were 7.0±9.7 kg (5.8±7.9%) with banding, 21.4±16.0 kg (16.4±11.6%) with sleeve gastrectomy, and 36.6±19.5 kg (26.1±12.2%) with gastric bypass (P<0.001). Rates of hypertension, diabetes, and dyslipidemia decreased to a significantly greater degree with surgery than medical management (P<0.001) and stayed the same or increased in wait-listed subjects.

Conclusions:

Population-based bariatric care, particularly bariatric surgery, was clinically effective. Weight and cardiometabolic risk was relatively stable wait-listed patients receiving “usual care.”

Copyright © 2013 by Lippincott Williams & Wilkins

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.